Brief: Osmotica Pharmaceuticals Posts Qtrly Loss Per Share $0.28
16/08/2021 21:15
Aug 16 (Reuters) - Osmotica Pharmaceuticals PLC OSMT.O :
* REPORTS SECOND QUARTER 2021 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q2 REVENUE $11.5 MILLION VERSUS $200,000
* QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX6H9L1f
Further company coverage: OSMT.O
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius